Risk, perhaps you should re-read Gerald's latest Chairman's Blog from July 9th, where the bridge study is discussed and a clear explanation of all the data he is presenting at the AAIC.

http://www.thechairmansblog.com/amarantus-bio...version-2/

There have been a number of studies already completed with LymPro, which are summarized in the blog post and the presentation. Sorry, but I don't feel much motivation to dig up all that and rehash it here. Perhaps someone else will. I'm about to get away from my computer and do something else for the rest of the afternoon.